Joanna Fares, Director of Drug Development Sciences
Professional Overview
Joanna Fares is a seasoned pharmaceutical professional with extensive experience in drug development sciences. As the Director of Drug Development Sciences at DiogenX, she leverages her deep expertise in pharmacology, preclinical studies, and project management to drive innovative therapeutic solutions.
Experience Summary
Current Role
As the Director of Drug Development Sciences at DiogenX, Joanna is responsible for overseeing the company's preclinical research and development efforts. She leads a team of scientists and project managers, ensuring the seamless execution of complex drug discovery and development programs. Joanna's strategic vision and technical acumen have been instrumental in advancing DiogenX's pipeline and securing significant industry partnerships.
Career Progression
Prior to her current role, Joanna served as the Pharmacology & Safety Manager at Emergence Therapeutics, which was later acquired by Eli Lilly & Company. In this position, she played a pivotal role in the development and successful regulatory approval of a novel oncology drug. Earlier in her career, Joanna held several senior-level roles at Innate Pharma, where she contributed to the advancement of multiple drug candidates through preclinical and early-stage clinical trials.
Joanna's academic background includes a Postdoctoral Fellowship at the Institut Paoli-Calmettes and a Doctoral Degree in Pharmacology from the National Cancer Institute, where she conducted groundbreaking research on tumor microenvironment and immunotherapeutic strategies.
Areas of Expertise
- Extensive experience in drug discovery and preclinical development
- Proficient in pharmacology, toxicology, and translational research
- Expertise in project management and cross-functional team leadership
- Proven track record in developing and executing strategic research plans
- Exceptional analytical and problem-solving skills
- Adept at fostering collaborative partnerships with industry and academic stakeholders
Professional Impact
During her tenure at Emergence Therapeutics, Joanna played a pivotal role in the successful regulatory approval of a novel oncology drug, significantly contributing to the company's growth and market impact. At Innate Pharma, her leadership and scientific contributions were instrumental in advancing multiple drug candidates through preclinical and early-stage clinical trials, expanding the company's pipeline and enhancing its industry reputation.
Conclusion
Joanna Fares is a highly accomplished pharmaceutical professional with a strong track record of driving innovation and delivering results in the drug development sciences. As the Director of Drug Development Sciences at DiogenX, she is poised to continue her impactful career, leveraging her deep expertise and strategic vision to advance the company's pipeline and contribute to the development of groundbreaking treatments.
